Published in Br Med J on March 19, 1977
Treatment of chronic heart failure: a review of recent drug trials. Br Med J (Clin Res Ed) (1985) 1.41
Comparative pharmacokinetics and pharmacodynamics of cardiac glycosides. Br J Clin Pharmacol (1980) 1.11
Measurement of systolic time intervals. Br J Clin Pharmacol (1978) 0.98
A score for prescribing digoxin. Br Heart J (1978) 0.95
Evaluation of digitalis in cardiac failure. Br Med J (Clin Res Ed) (1982) 0.92
Maintenance of the inotropic effect of digoxin on long-term treatment. Br Med J (Clin Res Ed) (1982) 0.90
Digoxin for heart failure in sinus rhythm. Thorax (1979) 0.87
The paradox of the lack of the efficacy of digitalis in congestive heart failure with sinus rhythm. Br J Clin Pharmacol (1979) 0.85
Drug treatment of heart failure. Br Heart J (1985) 0.84
William Withering and digitalis, 1785 to 1985. Br Med J (Clin Res Ed) (1985) 0.83
The future role of inotropic drugs. Drugs (1986) 0.79
Changing digoxin potency and cardiac mortality in England and Wales 1968-76. Br Heart J (1985) 0.77
Therapeutic strategies in congestive heart failure and the new inotrope-vasodilator agents. West J Med (1985) 0.75
Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment. Br Heart J (1989) 0.75
The role of digitalis in the future. Br J Clin Pharmacol (1984) 0.75
Digoxin in sinus rhythm [ editorial]. Br Med J (1979) 0.75
A new look at digoxin in congestive heart failure and sinus rhythm. Postgrad Med J (1989) 0.75
Use of digitalis in general practice. Liverpool Therapeutics Group. Br Med J (1978) 0.75
Systolic time intervals in heart failure in man. Circulation (1968) 8.18
Blood levels of drug at the equilibrium state after multiple dosing. Nature (1965) 3.37
Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med (1971) 3.27
Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration. J Clin Invest (1970) 2.66
Can digoxin dose requirements be predicted? Br J Clin Pharmacol (1976) 2.43
Clinical significance of positive inotropic action of digoxin in patients with left ventricular disease. Br Heart J (1973) 2.02
Fallibility of plasma-digoxin in differentiating toxic from non-toxic patients. Lancet (1971) 1.85
Effect of digitalis on systolic time intervals in heart failure. Am J Med Sci (1970) 1.76
Relationship of plasma digitoxin and digoxin to cardiac response following intravenous digitalization in man. Circulation (1970) 1.54
Studies on digitalis. VI. Reduction of the oxygen debt after exercise with digoxin in cardiac patients without heart failure. Circulation (1963) 1.26
Blind study on the action of digitoxin on elderly women. Am Heart J (1969) 1.17
Letter: Starting digoxin. Lancet (1976) 0.86
Can digoxin dose requirements be predicted? Br J Clin Pharmacol (1976) 2.43
A quinine a day keeps the leg cramps away? Br J Clin Pharmacol (1987) 1.96
Salbutamol aerosol causes a tachycardia due to the inhaled rather than the swallowed fraction. Br J Clin Pharmacol (1980) 1.61
Parkinsonism: siblings share Helicobacter pylori seropositivity and facets of syndrome. Acta Neurol Scand (1999) 1.48
Effects of nifedipine on resistance vessels, arteries and veins in man. Br J Clin Pharmacol (1980) 1.48
Digoxin prescribing: an evaluation of clinical judgment. Br Med J (1978) 1.41
Ideal sampling time for drug assays. Br J Clin Pharmacol (1980) 1.40
Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism. Acta Neurol Scand (1999) 1.38
Bradyphrenia and parkinsonism. Age Ageing (1994) 1.38
Nifedipine in the treatment of hypertension: report of a double-blind controlled trial. Br J Clin Pharmacol (1982) 1.34
Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci (1983) 1.25
Response of forearm resistance vessels to verapamil and sodium nitroprusside in normotensive and hypertensive men: evidence for a functional abnormality of vascular smooth muscle in primary hypertension. Clin Sci (Lond) (1982) 1.21
Hepatitis A virus-associated cholecystitis. Ann Intern Med (1994) 1.20
Adrenoceptor blockade of the circulatory responses to intravenous isoproterenol. Clin Pharmacol Ther (1978) 1.08
Cortisol is higher in parkinsonism and associated with gait deficit. Acta Neurol Scand (1998) 1.01
Ethylene chlorohydrin intoxication with fatality. Arch Dis Child (1970) 0.99
Comparative dilator effect of verapamil and sodium nitroprusside in forearm arterial bed and dorsal hand veins in man: functional differences between vascular smooth muscle in arterioles and veins. Cardiovasc Res (1979) 0.98
Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom. Br Med J (1976) 0.96
A score for prescribing digoxin. Br Heart J (1978) 0.95
Breadth of base whilst walking: effect of ageing and parkinsonism. Age Ageing (1998) 0.95
Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapy. Br J Clin Pharmacol (1990) 0.94
Evaluation of the safety of enalapril in the treatment of heart failure in the very old. Eur J Clin Pharmacol (1988) 0.93
Is this walk normal? Age Ageing (1993) 0.88
Bringing gait analysis out of the laboratory and into the clinic. Age Ageing (1988) 0.87
Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa. Br J Clin Pharmacol (1987) 0.87
Letter: Starting digoxin. Lancet (1976) 0.86
Link between Helicobacter pylori infection and idiopathic parkinsonism. Med Hypotheses (2000) 0.86
Digoxin: linearity between dose and serum concentration. Br J Clin Pharmacol (1976) 0.85
Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens? Clin Pharmacokinet (1991) 0.85
Quantification of the cardinal signs of parkinsonism and of associated disability in spouses of sufferers. Age Ageing (1993) 0.84
Significantly higher frequency of Helicobacter suis in patients with idiopathic parkinsonism than in control patients. Aliment Pharmacol Ther (2013) 0.83
Hypothesis: age-associated changes in gait represent, in part, a tendency towards parkinsonism. Age Ageing (1992) 0.83
Intravenous injection of gentamicin and tobramycin without impairment of hearing. J Infect Dis (1976) 0.83
Parkinsonism: differential age-trend in Helicobacter pylori antibody. Aliment Pharmacol Ther (2000) 0.83
Time course of physical and psychological responses to selegiline monotherapy in newly diagnosed, idiopathic parkinsonism. Eur J Clin Pharmacol (1996) 0.82
Compliance with anti-tuberculous therapy: a field trial of a pill-box with a concealed electronic recording device. Eur J Clin Pharmacol (1988) 0.81
Hypothesis: the bradyphrenia of parkinsonism is a nosological entity. Acta Neurol Scand (1993) 0.81
The paradox of using a 7 day antibacterial course to treat urinary tract infections in the community. Br J Clin Pharmacol (1988) 0.81
Defining small differences in efficacy between anti-parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor. Br J Clin Pharmacol (1993) 0.81
Therapeutic drug monitoring of digoxin: help or hindrance? Eur J Clin Pharmacol (1986) 0.80
Gait on a shoestring: falls and foot separation in parkinsonism. Age Ageing (1992) 0.80
Objective evidence for tolerance, against a background of improvement, during maintenance therapy with controlled release levodopa/carbidopa. Eur J Clin Pharmacol (1992) 0.80
Objective measurement of activation of rigidity: diagnostic, pathogenetic and therapeutic implications in parkinsonism. Br J Clin Pharmacol (1996) 0.80
Prescribing aids for gentamicin. Br J Clin Pharmacol (1974) 0.80
What makes a faller in early parkinsonism? Eur Neurol (1997) 0.80
Objective outcome criteria in trials of anti-parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypo-kinesia. Br J Clin Pharmacol (1991) 0.80
Parkinsonian abnormality of foot strike: a phenomenon of ageing and/or one responsive to levodopa therapy? Br J Clin Pharmacol (1990) 0.80
Measurement of compliance with medication: the sine qua non of clinical trials in old age? Age Ageing (1991) 0.79
Influence of diet on digoxin dose requirements. Br J Clin Pharmacol (1977) 0.79
A method for assessing responses of small arteries in man: effect of physiological and pharmacological stimuli. Clin Sci (Lond) (1981) 0.78
Effect of wholemeal and white bread on iron absorption in normal people. Br Med J (1977) 0.78
Effect of duration of levodopa/decarboxylase inhibitor therapy on the pharmacokinetic handling of levodopa in elderly patients with idiopathic Parkinson's disease. Eur J Clin Pharmacol (1991) 0.78
A functional abnormality of the forearm resistance vessels in men with primary hypertension. Gen Pharmacol (1983) 0.77
Reduced axial rotation in the spouses of sufferers from clinical idiopathic parkinsonism. Age Ageing (1992) 0.77
Could seborrhoeic dermatitis be implicated in the pathogenesis of parkinsonism? Acta Neurol Scand (1994) 0.77
Acquired tolerance to dilator action of hydrallazine during oral administration. Br J Clin Pharmacol (1980) 0.76
Effect of captopril on functional, physiological and biochemical outcome criteria in aged heart failure patients. Br J Clin Pharmacol (1992) 0.76
Prescribing digoxin in geriatric units: the unexplained variability in dosage requirements. Eur J Clin Pharmacol (1987) 0.76
Downward shift in serum IgM with Helicobacter pylori seropositivity. J Infect (2000) 0.76
Pressure sores: effect of Parkinson's disease and cognitive function on spontaneous movement in bed. Age Ageing (1988) 0.76
Screening for aminoglycoside auditory toxicity in the old. Br J Clin Pharmacol (1990) 0.75
Effect of treatment with chlorthalidone and atenolol on response to dilator agents in the forearm resistance vessels of men with primary hypertension. Br J Clin Pharmacol (1983) 0.75
Serum digoxin concentrations. Br J Clin Pharmacol (1976) 0.75
Oral digitalisation: choice of dose. Br Med J (1977) 0.75
Clinical pharmacology, therapeutics and geriatric medicine: an interaction of importance. Br J Clin Pharmacol (1991) 0.75
Evaluation of digoxin capsules in outpatients. Br Med J (1977) 0.75
Maintenance digoxin after an episode of heart failure. Br Med J (1977) 0.75
Equivalence of lanoxin tablets. Br J Clin Pharmacol (1976) 0.75